a Background Systemic hypertension is one of the main risk factors for atherothrombosis. Tissue factor (TF) is found in the adventitia of blood vessels and in the lipid core of atherosclerotic plaques, and is specifically expressed on monocyte or macrophage cell membrane surfaces. TF plays a pivotal role in blood clotting physiology and is involved in pro-inflammatory action and atherosclerotic plaque destabilization.
Tissue factor expression and activity are not increased in peripheral monocytes isolated from uncomplicated hypertensive patients Background Systemic hypertension is one of the main risk factors for atherothrombosis. Tissue factor (TF) is found in the adventitia of blood vessels and in the lipid core of atherosclerotic plaques, and is specifically expressed on monocyte or macrophage cell membrane surfaces. TF plays a pivotal role in blood clotting physiology and is involved in pro-inflammatory action and atherosclerotic plaque destabilization.
Objective In this study we investigated whether there is any relationship between TF messenger RNA expression and activity in blood monocytes isolated from hypertensive patients with clinical signs of atherosclerosis, uncomplicated hypertensive individuals and normotensive control subjects.
Methods Eighty subjects (41 men and 39 women, mean age 41 W 12 years) with untreated essential hypertension and 41 control subjects matched for sex and age were enrolled in the study. Patients were classified according to whether they had a normal (< -1 mm, 41 patients) or abnormal (> 1 mm, 39 patients) intima-media thickness (IMT).
Results TF mRNA expression and activity in hypertensive individuals with no carotid atherosclerosis were no different from control subjects in unstimulated and stimulated monocytes. Abnormal IMT patients showed a higher TF mRNA expression compared with normal IMT hypertensive subjects (P < 0.001).
Conclusions We demonstrated that TF mRNA and activity levels in monocytes obtained from uncomplicated hypertensive individuals are comparable with those of normotensive subjects, whereas atherosclerotic hypertensive patients showed increased levels of these parameters. J Hypertens 24:731-736 Q 2006 Lippincott Williams & Wilkins.
Introduction
Elevated levels of blood pressure are associated with an increased risk of atherosclerosis and thrombotic-related complications. A pivotal role in the initiation and development of vascular damage in patients with an elevation of blood pressure is played by circulating monocyte cells [1] [2] [3] [4] [5] [6] [7] [8] . Monocytes are actually involved in numerous pathophysiological processes, including inflammation, wound repair, atherosclerosis and thrombosis. Such properties are partly related to the ability of these cells to express inflammatory and procoagulant factors [9] [10] [11] , such as cell surface-associated tissue factor (TF).
TF is the cellular receptor and co-factor for plasma VII(a), which is capable of initiating the extrinsic coagulation cascade and also mediating angiogenesis, cell-to-cell interaction and signal transduction pathways [12] [13] [14] .
TF is normally not expressed in circulating monocytes and endothelial cells; however, its transcription can be transiently induced by pro-inflammatory stimuli [15] .
It has been demonstrated that TF is overexpressed in atherosclerotic lesions and is associated with macrophages and smooth muscle cells in lipid core plaque areas. When plaque rupture occurs TF is exposed by macrophages in the vessel wall, and interacting with circulating coagulation factors contributes to local thrombosis [16, 17] . In atherectomy specimens from patients with unstable angina (the clinical symptom of plaque rupture) TF macrophage expression was found to be greater than in those obtained from patients with either stable angina or myocardial infarction [18] . Furthermore, individuals with unstable angina showed greater TF expression and activity in circulating monocytes [19] and more elevated levels of plasma-shed membrane microparticles with procoagulant activity [20] . These observations suggest that TF is a key mediator of increased thrombogenicity in arterial lesions.
In systemic hypertension a prothrombotic state has already been reported. An increase in plasma TF antigen has been found in hypertensive individuals with additional risk factors and atherosclerosis [21] . Circulating monocytes isolated from hypertensive individuals have been seen to produce more inflammatory cytokines and have a greater power to adhere to cultivated endothelial cells compared with monocytes obtained from normotensive controls [3, 4] . A number of experimental studies have indicated an increase in TF expression and activity in human endothelial cells cultured under altered flow conditions [22] [23] [24] [25] , such as shear stress, cyclic strain and elevated static pressure.
We investigated whether there is any relationship between TF messenger RNA expression and activity in blood monocytes isolated from different patients: (i) hypertensive individuals with clinical signs of atherosclerosis; (ii) uncomplicated hypertensive individuals; and (iii) normotensive control subjects.
Materials and methods

Subjects
Eighty subjects (41 men and 39 women, mean age 41 AE 12 years) with untreated essential hypertension and 41 control subjects matched for sex and age were enrolled in the study. Hypertensive individuals were all outpatients, and controls were recruited from hospital personnel. During the study period untreated hypertensive and controls subjects did not receive any medicaments. Blood pressure was measured after 15 min of quiet rest in the supported right arm of the seated subject with a mercury sphygmomanometer, cuff-size adjusted for arm circumferences. Phases I and V of the Korotkoff sounds were considered to indicate systolic blood pressure (SBP) and diastolic blood pressure (DBP), respectively. Three measurements performed with intervals of more than 2 min were averaged.
Only subjects with SBP of 140 mmHg or greater or DBP of 90 mmHg or greater were included in the study. Patients with secondary hypertension, body mass index of 30 or greater, smoking habit, alcohol consumption, abnormal electrocardiogram pattern, clinical history of coronary artery disease, diabetes mellitus, cholesterol levels of 6 mmol/l or greater and triglyceride levels of 2.5 mmol/l or greater, thyroid, liver or kidney diseases were excluded.
All patients underwent carotid Doppler ultrasonography and laboratory testing, including clinical chemistry and blood monocyte isolation.
Informed consent was obtained from all participants, and the study was approved by the Ethics Committee of the University of Messina.
Ultrasound scanning procedure High-resolution B-mode ultrasound images (Vingmed CFM 750; Oslo, Norway) with a 7.0 MHz linear array transducer were used to measure the intima-media thickness (IMT). The carotid arteries were examined bilaterally in the areas of the common carotid (1 cm proximal to the carotid bulb), the carotid bifurcation (1 cm proximal to the flow divider) and the internal carotid artery (1 cm distal to the flow divider). All measurements were determined manually in longitudinal and transverse planes with anterior, lateral and posterior approaches. From B-mode images, single video frames were selected for IMT measurements.
The IMT was defined as the distance between the lumen/intima and the media/adventitia interfaces. For each parameter the mean value was calculated. The mean IMT was used as the key variable for statistical analysis, because of its strong association with cardiovascular disease [26] . Two independent readers, who were blinded with respect to the patients' clinical and laboratory results made the measurements and were over-read by one of the investigators. Patients were classified according to whether they had a normal ( 1 mm) or an abnormal (> 1 mm) IMT, including atheromatous plaques. The interobserver variability was evaluated on the measurements obtained from all subjects participating in the study. The interobserver variability of IMT measurements, as evaluated by comparing values obtained by two sets of scans evaluated by each reader, was 0.05 AE 0.03 mm (coefficient of variation 2.15%). The interobserver variability was 0.05 AE 0.02 mm (coefficient of variation 3.59%).
Monocyte isolation
Peripheral blood mononuclear cells were isolated from heparinized venous blood after overnight fasting. To minimize platelet contamination, the blood samples were centrifugated immediately at 500 g for 10 min at 48C. After removal of the plasma, the pellets were suspended in RPMI 1640 (ICN Biomedicals, Verona, Italy), supplemented with 2 mmol/l glutamine, 0.5% streptomycinpenicillin-fungizone and 10% fetal calf serum (FCS), and centrifuged over Ficoll-Paque (Pharmacia Fine Chemicals, Uppsala, Sweden) gradient at 1000 g for 20 min. Mononuclear cells were collected from the interface Ficoll/medium, suspended in RPMI 1640 and incubated in 35 mm plastic dishes for 90 min at 378C, in 5% carbon dioxide humid atmosphere. The monocytes were then obtained by their adherence to dishes, whereas the lymphocytes (non-adherent cells) were removed by aspiration with a Pasteur pipette and washing of the dishes with RPMI 1640. Cell preparations were more than 90% monocytes, as determined by non-specific esterase staining. After isolation, cells were incubated at 1 Â 10 6 cells/ml in RPMI 1640 at 378C, 5% carbon dioxide for 6 h. Cultures were performed in the presence or absence of lipopolysaccharide (Escherichia coli OB11:B4; Sigma, St Louis, Missouri, USA) at a final concentration of 0.1 mg/ml. At the end of the incubation period the cells (5 Â 10 5 cells/ml) were washed and frozen (À808C) in multiple vials until the analysis.
Monocyte tissue factor activity TF activity was determined in the cell lysate by measuring monocyte procoagulant activity with a one-stage clotting assay. Briefly, aliquots (100 ml) of cell lysate were added to (100 ml) of normal pooled citrate plasma of normal subjects; after 150 s of incubation at 378C, 100 ml of 0.025 mmol/L calcium chloride were added and the clotting time recorded using a coagulometer. All samples were tested in duplicate. Clotting times were converted to arbitrary TF units U/5 Â 10 5 monocytes using logarithmic plots of clotting times versus the dilution of a standard TF solution obtained using commercial thromboplastin (Thromborel; Dade Behring, Milan, Italy). Undiluted thromboplastin was assigned a value of 1000 TF units, corresponding to a clotting time of 18 s. The median of untreated control subjects' target levels was considered as the calibrator (1 Â sample), and the results were expressed as an n-fold difference compared with normal controls (relative expression levels).
Monocyte tissue factor expression by real-time reverse transcriptase-polymerase chain reaction Total RNA was extracted from 5 Â 10 5 cells using a commercial kit (Trizol reagent; Invitrogen, Milan, Italy) according to the manufacturer's instructions, and spectrophotometrically quantified (Biomate 3; Thermo Electron Corporation, Waltham, Massachusetts, USA). One microgram of total RNA was reverse transcripted using a highcapacity complementary DNA archive kit (Applied Biosystems, Monza, Milan, Italy) and random primers according to the manufacturer's instructions. An aliquot of 0.25 mg total cDNA was used to quantitate the amount of TF cDNA by the real-time reverse transcriptase polymerase chain reaction (PCR) method, as well as TATA binding protein cDNA as an endogenous control. Both reactions were carried out in the same tube (biplex) by Taq Man Universal PCR master mix and Assays on Demand ready-to-use primers and probes with a different reporter dye (Applied Biosystems).
The progression of PCR was monitored by the 7500 realtime PCR System (Applied Biosystems), and the relative quantitation was determined by the standard curve method for both target and endogenous reference. After normalization, the median of TF target levels in unstimulated monocytes from control subjects was considered as the calibrator (1 Â sample) and the results were expressed as an n-fold difference compared with normal controls (relative expression levels). The nucleotide sequence of some PCR products was confirmed by direct sequencing using the Big Dye cycle sequencing kit and ABI Prism sequencer analyser (Applied Biosystems) with a 5 0 internal primer.
Statistical analysis
The data are expressed as means and standard deviations (SD). The results were analysed to verify the normality of distribution using the Kolmogorov-Smirnov test, to accept abnormality of data. Therefore, all inferential analysis has been performed using non-parametric statistical tests. In particular, the Kruskal-Wallis test was used between groups [controls and hypertensive individuals with normal ( 1 mm) or abnormal (> 1 mm) IMT] and Wilcoxon's test for data obtained from stimulated and unstimulated monocytes. To avoid the hypothesis of null data in the Kruskal-Wallis test, a statistical nonparametric method for multiple comparisons was used. Multiple regression analysis was used to assess the contribution of the dependent variable (TF basal and IMT) in the regression equation.
Values of P < 0.05 were considered statistically significant. P values were calculated by a two-sided test.
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Results
Characteristics of the study subjects
The baseline characteristics of the study groups are shown in Table 1 Evaluation of tissue factor mRNA expression and activity TF mRNA expression and activity was evaluated in unstimulated (a) and lipopolysaccharide-stimulated (b) monocytes isolated from controls and hypertensive subjects. Both unstimulated and stimulated monocytes from all hypertensive subjects showed TF mRNA levels (a ¼ 1 versus 1.13 AE 0.16 n-fold; P < 0.001 and b ¼ 1.52 AE 0.12 versus 1.99 AE 0.68 n-fold; P < 0.001) and activity (a ¼ 1 versus 1.79 AE 1.0 n-fold; P < 0.001 and b ¼ 89 AE 28 versus 164 AE 64 n-fold; P < 0.001) significantly higher with respect to controls (Fig. 1) .
Monocyte TF mRNA expression in hypertensive individuals with no carotid atherosclerosis were no different from control subjects in unstimulated [a ¼ 1 (iii) versus 1.01 AE 0.06 (ii), n-fold] and stimulated [b ¼ 1 1.52 AE 0.12 (iii) versus 1.51 AE 0.16 (ii), n-fold] monocytes, whereas IMT abnormal patients showed greater TF mRNA expression in unstimulated (a ¼ 1 1.31 AE 0.06 n-fold; P < 0.001 versus iii and ii) and lipopolysaccharide-stimulated (B ¼ 2.7 AE 0.48 n-fold; P < 0.001 versus iii and ii) monocytes compared with normal IMT hypertensive subjects and controls (Fig. 2) .
In the same way, TF activity levels were significantly higher in abnormal IMT subjects with respect to control and normal IMT subjects in unstimulated [a ¼ 1 (iii), 1.06 AE 0.6 (ii), 2.39 AE 1.27 (i) n-fold; P < 0.001 versus ii and iii] and lipopolysaccharide-stimulated [b ¼ 89 AE 28 (iii), 103 AE 15 (ii), 213 AE 51 (i) n-fold; P < 0.001 versus ii and iii] monocytes (Fig. 2) .
To assess the contribution of the study variables in determining the monocyte TF mRNA basal expression and carotid IMT in hypertensive subjects, multiple regression analysis was used. The independent variables IMT (r ¼ 0.873; P < 0.001), fibrinogen (r ¼ 0.782; P < 0.001) and SBP (r ¼ 0.487; P < 0.01) significantly entered into the multiple regression model, suggesting that monocyte TF mRNA basal expression was strongly influenced by these factors (Table 2) . Similarly, consid- Tissue factor messenger RNA expression in unstimulated (black) and stimulated (white) monocytes isolated from the blood of control, hypertensive, 1 mm or less and over 1 mm intima-media thickness (IMT) hypertensive subjects. Means AE SD are given of all the measurements. Ã P < 0.001 to controls and ÃÃ P < 0.001 to controls, all hypertensive, and hypertensive individuals with IMT of 1 mm or less or more than 1 mm. Tissue factor activity values in unstimulated (black) and stimulated (white) monocytes, see Fig. 1 for further details. Means AE SD are given of all the measurements. Ã P < 0.001 to controls and ÃÃ P < 0.001 to controls, all hypertensive, and hypertensive individuals with intimamedia thickness (IMT) of 1 mm or less or more than 1 mm.
ering carotid IMT as a dependent factor, SBP and fibrinogen significantly correlated with IMT. However, when monocyte TF mRNA expression was also considered, SBP and fibrinogen were excluded from the stepwise multiple regression model because of the high correlation occurring between IMT and TF mRNA (r ¼ 0.873; P < 0.001), thus confirming the strong dependence of IMT on TF RNA expression.
Furthermore, because sex affects the coagulation system and the prevalence of hypertension, particularly in younger individuals, we analysed women and men separately. Nevertheless, no difference was detected among study parameters with respect to sex, including SBP and DBP, TF expression and activity and fibrinogen levels.
Discussion
A pro-thrombotic state in hypertension is well documented. Miller et al. [5] suggested that in systemic hypertension there is an enhanced TF expression, by activated monocytes. A link between the activation of monocyte angiotensin-1 receptor and the synthesis of TF was also reported [6, 8] . According to these findings, angiotensin-1 receptor antagonist drugs significantly reduced monocyte TF expression in healthy subjects [7] and also plasma TF activity in hypertensive patients [27] . Moreover, circulating monocytes derived from patients with elevated levels of blood pressure were found to express significantly higher levels of the inflammatory cytokines, TNF-a, a TF inducer, and IL-1b, than normal donors, suggesting an activation of these cells in systemic hypertension [3, 4] . In the past few years a number of in-vitro studies have demonstrated that the exposure of human endothelial cells to haemodynamic forces may modify the expression of target genes involved in regulating vascular homeostasis, including the TF gene [22] [23] [24] [25] . The human TF gene promoter region contains binding sites for the transcription factor activator protein 1, nuclear factor kappa B/Rel, Egr-1 and Sp-1 [28, 29] . Specific inflammatory mediators, including lipopolysaccharide, appear to induce the transcriptional activation of the TF gene by nuclear translocation of cRel/p 65 heterodimers [30] and functional interaction between activator protein 1 sites bound c-Fos/c Jun and the kB site bound cRel/p65 heterodimers [31] . An alternative mechanism proposed for the shear stress activation of TF gene regulation involves the activation of Egr-1 [25] and the flow-induced increase in the serine phosphorylation of Schwangerschaftsprotein 1 nuclear transcription factors [22] , thus haemodynamic forces can play a pivotal role in influencing the initiation, localization and development of atherosclerotic vascular disease.
In the present study we demonstrated that in monocytes from hypertensive subjects with no additional risk factors and carotid lesions, TF expression and activity levels were comparable with those of normotensive controls, suggesting that TF expression is influenced by mechanisms other than elevated blood pressure. By contrast, hypertensive individuals with carotid atherosclerosis have significantly greater TF expression and activity.
Grabowski and Lam [32] found that although flow increases the functional activity of TF produced by monolayers of fibroblast, it had no significant effect on endothelial cells [32] . Furthermore, Matsumoto et al. [33] reported that shear forces attenuated TF expression in cultured human endothelial cells, underlying the fact that fluid forces may act on the endothelium to render antithrombotic functions. In the light of these findings, it could be speculated that in the early stage of atherosclerosis, before the formation of arterial intimal lesions, even if circulating monocytes present signs of activation, the TF gene should be relatively inhibited. In addition, an opposite role of pressure on TF expression and activity should be played by different cell mechanisms [33] .
We also showed that hypertensive individuals with carotid atherosclerosis had a significant increase in monocyte TF mRNA and activity levels compared with hypertensive individuals with no carotid lesions. TF is highly expressed in atherosclerotic plaques, and its content has been related to plaque thrombogenicity [16] [17] [18] [19] . It has recently been reported that patients with cardiovascular risk factors such as diabetes mellitus, hypercholesterolemia and smoking, which are associated with a high incidence of atherothrombotic complications, showed an elevated blood-borne pool of TF, suggesting that the increased blood thrombogenicity may trigger a vascular event even in the absence of plaque disruption [34] .
The source of blood TF is unknown, but enhanced TF expression in circulating monocytes may be a candidate, thus confirming the finding that TF expression and activity may be upregulated in the monocytes of hypertensive individuals with carotid atherosclerosis and no other risk factors [35] . An insight into the procoagulant state in patients with elevated blood pressure has
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Even if the number of patients included in our study is small, it should be underlined that all participants were clinically well-defined and strictly selected. Nevertheless, our data extend the previous observation to human monocytes. We demonstrated for the first time, that TF mRNA and activity levels in monocytes derived from uncomplicated hypertensive individuals are comparable to those of normotensive subjects; in contrast atherosclerotic hypertensive patients showed increased levels of these parameters.
